Open AccessPD33-11 NEOADJUVANT CHEMOTHERAPY IN BLADDER CANCER: P53-NESS IS ASSOCIATED WITH CHEMO-RESISTANCE AND UNFAVORABLE OUTCOME
Author(s) -
Roland Seiler,
Woonyoung Choi,
Nicholas Erho,
Bernhard Kiss,
Lucia L.C. Lam,
Qici Wang,
Christine Bürki,
Elai Davicioni,
George N. Thalmann,
David J. McConkey,
Peter C. Black
Publication year - 2016
Publication title -
the journal of urology
Language(s) - English
Resource type - Journals
eISSN - 1527-3792
pISSN - 0022-5347
DOI - 10.1016/j.juro.2016.02.720
Subject(s) - medicine , bladder cancer , gemcitabine , cystectomy , cisplatin , chemotherapy , vinblastine , regimen , oncology , doxorubicin , cancer , gynecology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom